Načítá se...
Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
A search of the scientific literature for Daratumumab and myeloma gives more than 600 results (January 2021), which reflects the interest and activity around this antibody, an interest that was also reflected by the assignment of breakthrough designation for Daratumumab as a treatment for multiple m...
Uloženo v:
| Vydáno v: | J Clin Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958124/ https://ncbi.nlm.nih.gov/pubmed/33801271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|